Harvard Bioscience Inc.
HBIO | NASDAQ
$8.09
+$0.14 (+1.76%)
Sep 21, 2026, 3:08 PM ET · Market open
Market Data
Market Cap $35.86M
Enterprise Value $73.56M
Beta 1.53
Average Volume 21.99K
Shares Outstanding (Diluted) 4.53M
Shares Change YoY 2.16%
Institutional Ownership 35.45%
Exchange NASDAQ
ISIN US4169062043
Price Performance
Price Change 1M 11.7%
Price Change 3M 31.2%
Price Change 6M 48.9%
Price Change YTD 21.9%
Price Change 1Y 64.6%
Price Change 3Y -80.6%
Price Change 5Y -89.7%
1M CAGR (ann.) 28.4%
1Y CAGR (ann.) 70.6%
5Y CAGR (ann.) -36.5%
All-Time CAGR -7.7%
Valuation
PE Ratio -3.41
Forward PE 11.38
PEG Ratio -0.05
Forward PEG 0.01
PS Ratio 0.41
Forward PS 0.40
PB Ratio 4.83
P/FCF Ratio -25.43
P/Adj. FCF Ratio -16.35
P/OCF Ratio 56.79
EV/Sales 0.84
EV/EBIT -10.29
EV/EBITDA -78.34
EV/FCF -52.17
Earnings Yield -29.3%
FCF Yield -3.9%
Adj. FCF Yield -6.1%
Financial Health
Net Debt $30.18M
Total Debt $44.21M
Cash & Short-Term Investments $6.5M
Total Assets $76.29M
Current Ratio 1.87
Quick Ratio 0.98
Debt / Equity Ratio 5.96
Debt / EBITDA -47.08
Debt / FCF -31.35
OCF / Debt 0.01
Interest Coverage 0.30
Altman Z-Score -2.56
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 58.2%
Operating Profit Margin 1.2%
EBITDA Margin -1.1%
Net Profit Margin -11.9%
FCF Margin -1.6%
Adj. FCF Margin -2.5%
SBC / Revenue 1.2%
SBC Impact (per share) -55.5%
Returns
Return on Assets -13.7%
Return on Equity -92.0%
Return on Invested Capital 1.9%
Return on Capital Employed 2.0%
Return on Tangible Assets -17.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -8.4%
Revenue CAGR 5Y -4.6%
Revenue CAGR 10Y -2.0%
EPS CAGR 3Y 1.4%
EPS CAGR 5Y -35.9%
EPS CAGR 10Y -23.7%
FCF CAGR 3Y -128.0%
FCF CAGR 5Y 12.7%
FCF CAGR 10Y -4.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $38
Price Target Upside 378.0%
Cash Flow
Operating Cash Flow $651K
Free Cash Flow $-1.41M
Adj. Free Cash Flow $-2.19M
FCF Per Share -$0.31
OCF Per Share $0.14
OCF/S Ratio 0.7%
Income Statement
Revenue $87.81M
Gross Profit $51.07M
Operating Income $1.03M
EBITDA $-939K
Net Income $-10.41M
EPS (Diluted) -$2.33
Revenue / Employee $267.71K
Profit / Employee $-31.74K
Employees 328
Add to Watchlist
Select watchlists to add or remove HBIO